Gefitinib (Iressa) for the first-line treatment of non-small cell lung cancer

Authors
Category Structured summary of systematic reviews
JournalHTA Database
Year 2010
RECORD STATUS: None CITATION: Nachtnebel A. Gefitinib (Iressa) for the first-line treatment of non-small cell lung cancer Vienna: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA). Decision Support Document: Horizon Scanning in Oncology Vol. 06. 2010
Epistemonikos ID: 0ab259494ee331c4e10d520bc0c7adbbd3486249
First added on: Feb 05, 2015